DD: APONTIS PHARMA AG: Silke Reineke, buy

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them 05.05.2023 / 15:35 CET/CEST The issuer is solely responsible for the content of this announcement. 1. Details of the person discharging managerial responsibilities / person closely associated a) Name Title: First name: Silke Last name(s): Reineke 2. Reason for the notification a) Position / status Person closely associated with: Title: First name: Karlheinz Last name(s): Gast Position: Member of the managing body b) Initial notification 3. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor a) Name APONTIS PHARMA AG b) LEI 894500ETO1J6MR8PDF91  4. Details of the transaction(s) a) Description of the financial instrument, type of instrument, identification code Type: Share ISIN: DE000A3CMGM5 b) Nature of the transaction Acquisition c) Price(s) and volume(s) Price(s) Volume(s) 7.3250 EUR 36625.0000 EUR d) Aggregated information Price Aggregated volume 7.3250 EUR 36625.0000 EUR e) Date of the transaction 04/05/2023; UTC+2 f) Place of the transaction Name: Tradegate MIC: TGAT 05.05.2023 CET/CEST The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. Archive at www.eqs-news.com

Language:	English
Company:	APONTIS PHARMA AG
	Alfred-Nobel-Str. 10
	40789 Monheim
	Germany
Internet:	https://apontis-pharma.de/

End of News	EQS News Service

82983  05.05.2023 CET/CEST